IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1301-1310 out of 1310.

<< < 48 | 49 | 50 | 51 | 52 | 53

Public Release: 2-Nov-2015
Cellular and Molecular Gastroenterology and Hepatology
Studying cancer DNA in blood may help personalize treatment in liver cancer
Fragments of cancer DNA circulating in a patient's bloodstream could help doctors deliver more personalized treatment for liver cancer, researchers at Hiroshima University, Japan report.
Japanese Ministry of Health, Labor and Welfare, Japanese Ministry of Education Culture Sports Science and Technology, Government of Japan, and others

Contact: Norifumi Miyokawa
pr-research@office.hiroshima-u.ac.jp
Hiroshima University

Public Release: 2-Nov-2015
Nature Immunology
Cancer cells hijack glucose, alter immune cells
When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don't have the weapons to kill the cancer.
National Institutes of Health, Chinese Ministry of Science and Technology, Wuhan Union Hospital Research Fund, varian Cancer Research Fund, Marsha Rivkin Center for Ovarian Cancer Research, Barbara and Don Leclair

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 2-Nov-2015
Proceedings of the National Academy of Sciences
Antiangiogenic breast cancer treatment may benefit only patients with well-perfused tumors
A Massachusetts General Hospital research team, in collaboration with at Dana-Farber Cancer Institute investigators, may have found a reason why the use of antiangiogenesis drugs -- which has improved outcomes for patients with several types of cancer -- fails to benefit some breast cancer patients. In their report, the investigators describe how preoperative treatment with the antiangiogenic drug bevacizumab primarily benefited patients whose tumors were highly perfused with blood vessels prior to treatment.
Genentech, AVON National Cancer Institute Progress for Patients Program, Department of Defense Breast Cancer Research Innovator Award, NIH/National Cancer Institute

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital

Public Release: 2-Nov-2015
Nature Structural & Molecular Biology
First complete pictures of cells' DNA-copying machinery
The first-ever images of the protein complex that unwinds, splits, and copies double-stranded DNA reveal something rather different from the standard textbook view. The electron microscope images, created by scientists at the US Department of Energy's Brookhaven National Laboratory with partners from Stony Brook University and Rockefeller University, offer new insight into how this molecular machinery functions.
National Institutes of Health

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory

Public Release: 2-Nov-2015
National Cancer Research Institute Cancer Conference 2015
Quarter of Londoners diagnosed with cancer at A&E are dead within two months
A quarter of patients diagnosed with cancer after going to London A&E departments will have died within two months, according to research presented at the National Cancer Research Institute Cancer Conference in Liverpool.

Contact: Greg Jones
greg.jones@cancer.org.uk
07-050-264-059
Cancer Research UK

Public Release: 2-Nov-2015
Nature Chemical Biology
Griffith University reveals world-first 3-D image of a protein involved in cancer spread
Griffith University's world leading Institute for Glycomics has made scientific history by determining the first three-dimensional image of a protein linked to the spread of cancer.

Contact: Michael Jacobson
m.jacobson@griffith.edu.au
61-075-552-9250
Griffith University

Public Release: 1-Nov-2015
Cancer Research
Skin cancer-causing fusion gene identified
Fusion genes are hybrid genes formed as a result of gene rearrangement or mutation. They can be used to develop more effective treatments for cancers that express their own particular type of fusion gene. Researchers from Kumamoto and Kisato Universities in Japan have revealed a new fusion gene related to cutaneous angiosarcoma, a malignant form of skin cancer with a very poor survival rate. Its discovery will help to improve diagnostic and therapeutic techniques.

Contact: J. Sanderson
research-coordinator@jimu.kumamoto-u.ac.jp
Kumamoto University

Public Release: 1-Nov-2015
National Cancer Research Institute 2015
Cancer Cell
New treatment targets cancers with particular genetic signature
Oxford University's Dr Tim Humphrey and team found that cancer cells with a mutated SETD2 gene were killed by a drug called AZD1775 that inhibits a protein called WEE1.
Medical Research Council, Cancer Research UK, Swiss National Science Foundation

Contact: Tom Calver
news.office@admin.ox.ac.uk
44-186-527-0046
University of Oxford

Public Release: 1-Nov-2015
National Cancer Research Institute Cancer Conference
Around a fifth of unvaccinated ethnic school girls think they don't need HPV jab
Around 20 per cent of girls from ethnic minority backgrounds are not being vaccinated against the Human Papilloma Virus because they feel they don't need to have it.
Cancer Research UK

Contact: Stephanie McClellan
stephanie.mcclellan@cancer.org.uk
020-346-95314
Cancer Research UK

Public Release: 31-Oct-2015
National Cancer Research Institute Cancer Conference 2015
Heat-activated 'grenade' to target cancer
Researchers have developed cancer drug-packed 'grenades' armed with heat sensitive triggers, allowing for treatment to be targeted directly at tumours, according to two studies due to be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.
European Commission, North West Centre for Advanced Drug Delivery

Contact: Greg Jones
greg.jones@cancer.org.uk
44-020-346-98311
Cancer Research UK

Showing releases 1301-1310 out of 1310.

<< < 48 | 49 | 50 | 51 | 52 | 53

  Search News Releases

     

 

EurekAlert!